Stegmann Thomas 4
4 · CardioVascular BioTherapeutics, Inc. · Filed Aug 10, 2009
Insider Transaction Report
Form 4
Stegmann Thomas
10% Owner
Transactions
- Sale
Common Stock
2009-08-04$0.15/sh−107,000$16,585→ 20,583,008 total - Sale
Common Stock
2009-08-05$0.15/sh−242,335$36,350→ 20,220,608 total - Sale
Common Stock
2009-08-07$0.19/sh−200,000$38,000→ 17,320,608 total - Sale
Common Stock
2009-08-07$0.21/sh−200,000$42,000→ 16,920,608 total - Sale
Common Stock
2009-08-04$0.15/sh−120,065$18,010→ 20,462,943 total - Sale
Common Stock
2009-08-06$0.15/sh−200,000$31,000→ 19,620,608 total - Sale
Common Stock
2009-08-07$0.17/sh−200,000$34,000→ 18,820,608 total - Sale
Common Stock
2009-08-07$0.17/sh−400,000$70,000→ 18,420,608 total - Sale
Common Stock
2009-08-07$0.18/sh−500,000$90,000→ 17,920,608 total - Sale
Common Stock
2009-08-07$0.17/sh−200,000$33,000→ 19,020,608 total - Sale
Common Stock
2009-08-07$0.18/sh−400,000$74,000→ 17,520,608 total - Sale
Common Stock
2009-08-07$0.22/sh−200,000$44,000→ 16,720,608 total - Sale
Common Stock
2009-08-07$0.20/sh−200,000$40,000→ 17,120,608 total - Sale
Common Stock
2009-08-06$0.15/sh−400,000$60,000→ 19,820,608 total - Sale
Common Stock
2009-08-06$0.16/sh−200,000$32,000→ 19,420,608 total - Sale
Common Stock
2009-08-07$0.16/sh−200,000$32,000→ 19,220,608 total